Related Experiment Video
Updated: Nov 29, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
The Comparison Spondin 2 Levels in Primary Glomerular Diseases
Serdar Kahvecioglu1, Alparslan Ersoy2, Yasemin Üstundag3
1Department of Nephrology, Health Science University Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Serum Spondin 2 (SPON2) levels are elevated in various glomerular diseases but do not correlate with proteinuria. This finding suggests SPON2 may not be a direct biomarker for glomerular disease severity.
Area of Science:
- Nephrology
- Biochemistry
- Extracellular Matrix Biology
Background:
- Spondin 2 (SPON2) is an extracellular matrix protein involved in various biological processes.
- Understanding SPON2's role in kidney diseases is crucial for potential diagnostic and prognostic applications.
Purpose of the Study:
- To investigate serum SPON2 levels in patients with different glomerular diseases.
- To explore the correlation between serum SPON2 levels and renal function, including proteinuria.
- To compare SPON2 levels across various glomerular diseases and control groups.
Main Methods:
- Serum SPON2 levels were measured in 97 adult patients with focal segmental glomerulosclerosis (FSGS), membranous glomerulonephritis (MN), IgA nephropathy (IgAN), membranoproliferative glomerulonephritis (MPGN), and AA amyloidosis.
- Control groups included patients with polycystic kidney disease (PKD) and healthy individuals.
- Statistical analysis was performed to correlate SPON2 levels with clinical parameters like proteinuria, serum uric acid, and triglyceride levels.
Main Results:
- Serum SPON2 levels were significantly higher in all investigated glomerular disease groups compared to healthy and PKD controls.
- Serum SPON2 levels were comparable across the different glomerular disease types (MN, FSGS, IgAN, MPGN, AA amyloidosis).
- Serum SPON2 levels showed a correlation with serum uric acid and triglyceride levels, but not with the grade of proteinuria.
Conclusions:
- Serum SPON2 levels are elevated in various glomerular diseases but do not differ significantly among them.
- SPON2 does not appear to be a reliable biomarker for assessing proteinuria severity in glomerular diseases.
- Further research is needed to elucidate the specific role of SPON2 in the pathogenesis and progression of glomerular diseases.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Nephrons

